Atossa Therapeutics
ATOS
#10504
Rank
S$25.87 M
Marketcap
S$2.59
Share price
1.26%
Change (1 day)
154.48%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -S$39.57 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$32.91 Million, an increase over its 2023 earnings that were of -S$38.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$39.57 Million20.24%
2024 -S$32.91 Million-15.25%
2023 -S$38.84 Million11.62%
2022 -S$34.79 Million30.84%
2021 -S$26.59 Million15.58%
2020 -S$23.01 Million3.41%
2019 -S$22.25 Million51.16%
2018 -S$14.72 Million40.41%
2017 -S$10.49 Million27.54%
2016 -S$8.22 Million-47.49%
2015 -S$15.65 Million-17.25%
2014 -S$18.92 Million35.91%
2013 -S$13.92 Million112.3%
2012 -S$6.56 Million46.53%
2011 -S$4.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.52 B-86,180.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.77 B-4,659.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.77 B-4,656.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$53.78 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$0.13 Billion 229.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-S$10.12 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA